Guo et al. showed that CD14 transcripts were significantly lower in the serum and tissue samples of HCC [52], demonstrating CD14 ability to distinguish HCC from liver cirrhosis, so it may be a potential biomarker for CD14 in HCC diagnosis. Here, CD14 is linked to cirrhosis of liver.